Creative Medical Technology Holdings Inc
NASDAQ:CELZ
Creative Medical Technology Holdings Inc
Research & Development
Creative Medical Technology Holdings Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Creative Medical Technology Holdings Inc
NASDAQ:CELZ
|
Research & Development
-$2.2m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Research & Development
-$8.8B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-8%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Research & Development
-$5.7B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-7%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Research & Development
-$7.2B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-6%
|
|
|
Astria Therapeutics Inc
NASDAQ:ATXS
|
Research & Development
-$98m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-17%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Research & Development
-$3.9B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-15%
|
|
Creative Medical Technology Holdings Inc
Glance View
Creative Medical Technologies, Inc. develops novel regenerative medicine and stem cell technologies. The company is headquartered in Phoenix, Arizona. The company went IPO on 2009-05-01. The firm conducts its commercial operations through its subsidiary, Creative Medical Technologies, Inc. (CMT). CMT markets and sells its CaverStem and FemCelz disposable kits utilized by physicians to perform autologous procedures that treat erectile dysfunction and female sexual dysfunction and female sexual dysfunction, respectively. The firm's products include CaverStem, FemCelz, StemSpine, Amniostem, ImmCelz and OvaStem. CaverStem utilizes a patient's own stem cells to treat erectile dysfunction (ED). FemCelz is used for the treatment and procedure for vaginal rejuvenation function.
See Also
What is Creative Medical Technology Holdings Inc's Research & Development?
Research & Development
-2.2m
USD
Based on the financial report for Sep 30, 2025, Creative Medical Technology Holdings Inc's Research & Development amounts to -2.2m USD.
What is Creative Medical Technology Holdings Inc's Research & Development growth rate?
Research & Development CAGR 3Y
-32%
Over the last year, the Research & Development growth was 4%. The average annual Research & Development growth rates for Creative Medical Technology Holdings Inc have been -32% over the past three years .
